ÂÜÀòÂÒÂ×

Antonin de Fougerolles is a prominent leader in the biopharmaceutical sector with extensive experience in research and executive roles. Currently serving as Board Chair for etherna and LIfT BioSciences, along with board memberships at Chimeron Bio and Walking Fish Therapeutics, Antonin has a proven track record of advancing innovative therapeutic approaches, particularly in mRNA technology and cell therapies. Previous positions include CEO of Evox Therapeutics, Chief Scientific Officer at Ablynx and Tolerx, and founding Chief Scientific Officer at Moderna Therapeutics, where Antonin played a crucial role in the development of the mRNA platform that underpins the COVID-19 vaccines. Educational credentials include a PhD in Immunology from Harvard University and a Bachelor of Science in Microbiology & Immunology from McGill University.